Considering the conflicting functions of TGF-β1 in cancer development, it is not surprising that general inhibition of TGF-β1 expression may accelerate the progression of preneoplastic lesions, in which TGF-β1 still acts as a tumor suppressor. This evidence concerns the gene TGFB1 and neoplasm.